Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Stijn De Keukeleire

Work address: C. Heymanslaan 10, ingang 12 - verdieping 2
9000 Gent
Email: StijnJ.DeKeukeleire@UGent.be

Show Sort by

Add to list
- Journal Article
- A1
- open access
Immuno-oncological biomarkers for squamous cell cancer of the head and neck : current state of the art and future perspectives

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Elien Hilgert (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) and Sylvie Rottey (UGent)

(2021) CANCERS. 13(7).
Add to list
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Zahra Mosala Nezhad (UGent) , Tessa Kerre (UGent) , Vibeke Kruse (UGent) , Hans Van Vlierberghe (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2021) IMMUNOTHERAPY. 13(5). p.409-418
Add to list
Verrucous hyperplasia and verrucous carcinoma in head and neck : use and benefit of methotrexate

Stijn De Keukeleire (UGent) , Astrid De Meulenaere (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) , Fréderic Duprez (UGent) , Olivier Bouckenooghe, Liesbeth Ferdinande (UGent) , David Creytens (UGent) and Sylvie Rottey (UGent)

(2021) ACTA CLINICA BELGICA.
Add to list
Targeting FGFR in bladder cancer : ready for clinical practice?

Stijn De Keukeleire (UGent) , Daan De Maeseneer (UGent) , Celine Jacobs (UGent) and Sylvie Rottey (UGent)

(2020) ACTA CLINICA BELGICA. 75(1). p.49-56
Add to list
To treat or not to treat? Managing comorbidities in cancer patients under immune checkpoint inhibition

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Gert De Schoenmakere, Vibeke Kruse (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2019) ACTA CLINICA BELGICA.